110 related articles for article (PubMed ID: 38236199)
1. Examining the spatial distribution of tumor-infiltrating immune cells in patients with stage I-IIIA LUAD.
Du W; Yang F; Hui Z; Zhang J; Shen M; Ren X; Wei F
J Leukoc Biol; 2024 Jan; ():. PubMed ID: 38236199
[TBL] [Abstract][Full Text] [Related]
2. Spatial architecture of regulatory T-cells correlates with disease progression in patients with nasopharyngeal cancer.
Zhou F; Shayan G; Sun S; Huang X; Chen X; Wang K; Qu Y; Wu R; Zhang Y; Liu Q; Zhang J; Luo J; Shi X; Liu Y; Liang B; Li YX; Wang J; Yi J
Front Immunol; 2022; 13():1015283. PubMed ID: 36439177
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of tumor immune microenvironment factors in patients with stage I lung adenocarcinoma.
Xue Q; Wang Y; Zheng Q; Chen L; Lin Y; Jin Y; Shen X; Li Y
Am J Cancer Res; 2023; 13(3):950-963. PubMed ID: 37034213
[TBL] [Abstract][Full Text] [Related]
4. Multiplex immunofluorescence and single-cell transcriptomic profiling reveal the spatial cell interaction networks in the non-small cell lung cancer microenvironment.
Peng H; Wu X; Liu S; He M; Xie C; Zhong R; Liu J; Tang C; Li C; Xiong S; Zheng H; He J; Lu X; Liang W
Clin Transl Med; 2023 Jan; 13(1):e1155. PubMed ID: 36588094
[TBL] [Abstract][Full Text] [Related]
5. Somatic mutations combined with clinical features can predict the postoperative prognosis of stage IIIA lung adenocarcinoma.
Li J; Lin X; Li X; Zhang W; Sun D
Ann Transl Med; 2022 Feb; 10(4):187. PubMed ID: 35280419
[TBL] [Abstract][Full Text] [Related]
6. Expression of PD1/PDL1 in gastric cancer at different microsatellite status and its correlation with infiltrating immune cells in the tumor microenvironment.
Wang YL; Gong Y; Lv Z; Li L; Yuan Y
J Cancer; 2021; 12(6):1698-1707. PubMed ID: 33613757
[No Abstract] [Full Text] [Related]
7. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer.
Ino Y; Yamazaki-Itoh R; Shimada K; Iwasaki M; Kosuge T; Kanai Y; Hiraoka N
Br J Cancer; 2013 Mar; 108(4):914-23. PubMed ID: 23385730
[TBL] [Abstract][Full Text] [Related]
8. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
9. Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors.
Andersen LB; Nørgaard M; Rasmussen M; Fredsøe J; Borre M; Ulhøi BP; Sørensen KD
J Pathol; 2021 Oct; 255(2):155-165. PubMed ID: 34255349
[TBL] [Abstract][Full Text] [Related]
10. Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death.
Tang B; Xu W; Wang Y; Zhu J; Wang H; Tu J; Weng Q; Kong C; Yang Y; Qiu R; Zhao Z; Xu M; Ji J
Clin Immunol; 2021 Nov; 232():108872. PubMed ID: 34648954
[TBL] [Abstract][Full Text] [Related]
11. Significantly different immunological score in lung adenocarcinoma and squamous cell carcinoma and a proposal for a new immune staging system.
Zeng Z; Yang F; Wang Y; Zhao H; Wei F; Zhang P; Zhang X; Ren X
Oncoimmunology; 2020; 9(1):1828538. PubMed ID: 33101777
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy.
Yang H; Wang K; Li S; Li Y; Yuan L
Pathol Oncol Res; 2021; 27():1609898. PubMed ID: 34447289
[No Abstract] [Full Text] [Related]
13. Macrophages-based immune-related risk score model for relapse prediction in stage I-III non-small cell lung cancer assessed by multiplex immunofluorescence.
Wu XR; Peng HX; He M; Zhong R; Liu J; Wen YK; Li CC; Li JF; Xiong S; Yu T; Zheng HB; Chen YH; He JX; Liang WH; Cai XY
Transl Lung Cancer Res; 2022 Apr; 11(4):523-542. PubMed ID: 35529784
[TBL] [Abstract][Full Text] [Related]
14. Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma.
Bian T; Zheng M; Jiang D; Liu J; Sun H; Li X; Liu L; Zhang J; Liu Y
Cancer Cell Int; 2021 Mar; 21(1):144. PubMed ID: 33653340
[TBL] [Abstract][Full Text] [Related]
15. Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer.
Backman M; Strell C; Lindberg A; Mattsson JSM; Elfving H; Brunnström H; O'Reilly A; Bosic M; Gulyas M; Isaksson J; Botling J; Kärre K; Jirström K; Lamberg K; Pontén F; Leandersson K; Mezheyeuski A; Micke P
Eur J Cancer; 2023 May; 185():40-52. PubMed ID: 36963351
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
Wang W; Ren S; Wang Z; Zhang C; Huang J
Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
[TBL] [Abstract][Full Text] [Related]
17. Dendritic Cell Vaccination in Metastatic Melanoma Turns "Non-T Cell Inflamed" Into "T-Cell Inflamed" Tumors.
Bulgarelli J; Tazzari M; Granato AM; Ridolfi L; Maiocchi S; de Rosa F; Petrini M; Pancisi E; Gentili G; Vergani B; Piccinini F; Carbonaro A; Leone BE; Foschi G; Ancarani V; Framarini M; Guidoboni M
Front Immunol; 2019; 10():2353. PubMed ID: 31649669
[TBL] [Abstract][Full Text] [Related]
18. HMMR associates with immune infiltrates and acts as a prognostic biomaker in lung adenocarcinoma.
Ma X; Xie M; Xue Z; Yao J; Wang Y; Xue X; Wang J
Comput Biol Med; 2022 Dec; 151(Pt A):106213. PubMed ID: 36306573
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry.
Rakaee M; Busund LR; Jamaly S; Paulsen EE; Richardsen E; Andersen S; Al-Saad S; Bremnes RM; Donnem T; Kilvaer TK
Neoplasia; 2019 Mar; 21(3):282-293. PubMed ID: 30743162
[TBL] [Abstract][Full Text] [Related]
20. M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer.
Cao L; Che X; Qiu X; Li Z; Yang B; Wang S; Hou K; Fan Y; Qu X; Liu Y
Cancer Manag Res; 2019; 11():6125-6138. PubMed ID: 31308749
[No Abstract] [Full Text] [Related]
[Next] [New Search]